Representative before the EPO

Employment test 51 - 200 employees
Company dna mewburn ellis llp
operating since 1890
Headquarter in London and 4 offices
active in Legal Services

Nicholas Robert Sutcliffe has worked on the following 121 EPO patent applications which have been published in the last five years:

EP11729797

BI-SPECIFIC FUSION PROTEINS

IPC classification:
C12N 15/62
Applicant:
Merrimack Pharmaceuticals, Inc.
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11731030

APPARATUS, KITS AND METHODS FOR THE PRODUCTION OF BIOMIMETIC CONSTRUCTS

IPC classification:
A61L 27/24, A61L 27/28, A61L 27/52, C12M 3/00
Applicant:
UCL Business plc
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11755098

IN VITRO HEPATIC DIFFERENTIATION

IPC classification:
C12N 5/071
Applicant:
Cambridge Enterprise Ltd.
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11844639

LISSENCEPHALY THERAPEUTIC AGENT

IPC classification:
A61K 9/08, A61K 31/27, A61K 31/341, A61K 31/351, A61K 31/44, A61K 38/00, A61P 25/00, C07K 5/023
Applicant:
Osaka City University
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP10835031

METHODS FOR TREATING CANCERS COMPRISING K-RAS MUTATIONS

IPC classification:
A61K 39/395, C07K 16/22, C07K 16/28, G01N 33/48, G01N 33/574
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP12712344

TREATMENT FOR PEANUT ALLERGY

IPC classification:
A61K 39/35
Applicant:
Cambridge Enterprise Ltd.
Applicant:
Cambridge University Hospitals NHS Foundation Trust
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP12718729

CELLULAR SUBSTRATE FOR NUCLEAR REPROGRAMMING

IPC classification:
C12N 5/078
Applicant:
Cambridge Enterprise Ltd.
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12776706

PRODUCTION AND DELIVERY OF A STABLE COLLAGEN

IPC classification:
A01N 37/12, A01N 37/44, A61K 31/195
Applicant:
Department of Veterans Affairs - Office of the General Counsel
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12728115

POPULATIONS OF SMOOTH MUSCLE CELLS OF SPECIFIC EMBRYONIC LINEAGES

IPC classification:
C12N 5/071
Applicant:
Cambridge Enterprise Ltd.
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12735365

METHODS FOR PREPARATIVE IN VITRO CLONING

IPC classification:
C12N 15/10
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11814752

ISLETS OF LANGERHANS TRANSPLANT USING ISLETS OF LANGERHANS AND ADIPOSE TISSUE DERIVED STEM CELLS

IPC classification:
A61K 35/28, A61K 35/39, A61P 3/10, A61P 43/00, C12N 5/07, C12N 5/071, C12N 5/0775
Applicant:
Osaka University
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP12822010

IMMUNOGENIC COMPOSITIONS AND METHODS THEREFOR

IPC classification:
A61K 39/09, A61K 39/145, A61K 39/155, A61K 39/21, A61P 31/22, C12N 15/62
Applicant:
The University of Queensland
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12827124

VACCINE PREPARATION FOR CANCER TREATMENT

IPC classification:
A61K 39/00, A61K 39/12, A61K 45/00, A61K 47/36, A61K 47/48, A61P 31/12, A61P 35/00, C07K 14/00, C07K 19/00, C12N 15/117
Applicant:
Tokyo Medical and Dental University
Applicant:
Mie University
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11838414

CATALYTIC HYDROPYROLYSIS OF ORGANOPHILIC BIOMASS

IPC classification:
C10G 1/02, C10G 1/06, C10G 1/08, C10G 11/18, C10G 45/02, C10G 47/00, C10G 47/02, C10G 49/00, C10L 1/02, C10L 9/08
Applicant:
KiOR Inc
Agent:
Phillip Brian Lucas, Lucas & Co.
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12833767

VEGF/DLL4 BINDING AGENTS AND USES THEREOF

IPC classification:
A61K 39/00, C07K 16/00, C12P 21/08
Applicant:
OncoMed Pharmaceuticals Inc
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12838386

PI-KINASE INHIBITORS WITH BROAD SPECTRUM ANTI-INFECTIVE ACTIVITY

IPC classification:
A01N 43/00
Applicant:
The Regents of the University of California
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12845990

MATERIAL HAVING PORES ON SURFACE, AND METHOD FOR MANUFACTURING SAME

IPC classification:
A61L 17/00, A61L 27/00, B24C 1/06, B24C 11/00, C04B 41/91, C08J 9/00, C08J 9/36, C22C 14/00
Applicant:
Kyoto University
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12850629

HUMAN NOTCH RECEPTOR MUTATIONS AND THEIR USE

IPC classification:
C07H 21/00, G01N 33/48
Applicant:
OncoMed Pharmaceuticals Inc
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11841531

TWO-STAGE REACTOR AND PROCESS FOR CONVERSION OF SOLID BIOMASS MATERIAL

IPC classification:
B01J 8/18, B01J 23/90, B01J 29/90, B01J 38/12, C10B 49/22, C10B 53/02, C10B 57/18, C10G 1/00, C10G 1/02
Applicant:
KiOR Inc
Agent:
Brian Ronald Lucas, Lucas & Co.
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12729620

PROCESS FOR MAKING CHITIN DERIVATIVES

IPC classification:
C12P 19/04
Agent:
Multiple attorneys, Arnold & Siedsma B.V.
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12730912

COMPOSITION COMPRISING CHITOSAN, GLUCOSAMINE AND AMINO ACIDS FOR AGRICULTURAL USE

IPC classification:
A01N 37/44, A01N 43/16, A01N 63/02, A01P 3/00, A01P 5/00, A01P 15/00
Agent:
Multiple attorneys, Arnold & Siedsma B.V.
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12774375

iPS CELL HAVING DIFFERENTIATION PROPENSITY FOR CORNEAL EPITHELIUM

IPC classification:
C12N 5/071, C12N 5/0735, C12N 5/074, C12N 5/079, C12N 5/10
Applicant:
Osaka University
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13733927

ANALYSIS AND TARGETING OF ROR2 IN CANCER

IPC classification:
G01N 33/574
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP13738232

HIGH AFFINITY SIRP-ALPHA REAGENTS

IPC classification:
A61K 38/16
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12868058

CANCER TREATMENT AND MONITORING METHODS USING OX40 AGONISTS

IPC classification:
A61K 39/00, C12Q 1/68
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12856612

STIMULATION OF OVARIAN FOLLICLE DEVELOPMENT AND OOCYTE MATURATION

IPC classification:
C12N 5/00
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12754339

PHYLLOSILICATE-BASED COMPOSITIONS AND METHODS OF MAKING THE SAME FOR CATALYTIC PYROLYSIS OF BIOMASS

IPC classification:
B01J 20/00, B01J 37/00, C10G 1/08, C10G 3/00
Applicant:
KiOR Inc
Agent:
Phillip Brian Lucas, Lucas & Co.
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12771088

IMPROVED CATALYST FOR THERMOCATALYTIC CONVERSION OF BIOMASS TO LIQUID FUELS AND CHEMICALS

IPC classification:
B01J 29/40, C10G 3/00
Applicant:
KiOR Inc
Agent:
Phillip Brian Lucas, Lucas & Co.
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13764988

TREATMENT OF PULMONARY HYPERTENSION WITH LEUKOTRIENE INHIBITORS

IPC classification:
A61K 31/165, A61K 31/4015, A61P 9/12
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12830223

TOPICAL ITRACONAZOLE FORMULATIONS AND USES THEREOF

IPC classification:
A61K 31/496, A61K 47/10, A61K 47/14, A61K 47/26, A61K 47/32, A61K 47/40, A61P 35/00
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12814264

RSPO BINDING AGENTS AND USES THEREOF

IPC classification:
A61K 38/17, A61K 39/395, A61K 45/06, A61P 35/00, C07K 14/71, C07K 16/18, C07K 16/28, C07K 16/30, C07K 16/46, G01N 33/574
Applicant:
OncoMed Pharmaceuticals Inc
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12800695

METHODS FOR INCREASING INSULIN SENSITIVITY AND TREATING DIABETES

IPC classification:
A61K 38/00, A61K 38/43, A61K 38/48, A61P 3/00, A61P 5/50, C12N 9/00, C12N 9/64, C12Q 1/00, C12Q 1/37, G01N 33/50
Applicant:
Johns Hopkins University
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13781751

GEL WITH SELF-RESTORABILITY AND SHAPE-MEMORY PROPERTY AND PROCESS FOR PRODUCING SAME

IPC classification:
C08F 2/10, C08F 220/10, C08F 220/54
Applicant:
Osaka University
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13790284

METHODS FOR TREATING CANCER WITH NOTCH2/3 ANTIBODIES

IPC classification:
A61K 39/395
Applicant:
OncoMed Pharmaceuticals Inc
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13740741

THERAPEUTIC IL-13 POLYPEPTIDES

IPC classification:
A61K 38/00, C07K 1/00
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13788066

METHODS AND COMPOSITIONS FOR PROVIDING A PREECLAMPSIA ASSESSMENT

IPC classification:
C12Q 1/68
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11813251

TREATMENT OF METABOLIC SYNDROME AND INSULIN RESISTANCE WITH CITRUS FLAVANONES

IPC classification:
A61K 31/352, A61K 31/7034, A61K 31/7048, A61P 3/08, A61P 3/10
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP13733195

CURCUMIN DERIVATIVES FOR MICROBIAL BIOFILM DESTRUCTION

IPC classification:
A01N 35/02, A61K 31/12, A61P 31/04
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13734473

TRANSCRIPTION FACTOR MEDIATED PROGRAMMING TOWARDS MEGAKARYOCYTES

IPC classification:
A61K 31/14, C12N 5/078, C12N 5/0789
Applicant:
Cambridge Enterprise Ltd.
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13809969

METHODS FOR NUCLEIC ACID ASSEMBLY AND HIGH THROUGHPUT SEQUENCING

IPC classification:
C40B 50/06
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12837648

METHOD FOR RECOGNITION OF SPEECH MESSAGES AND DEVICE FOR CARRYING OUT THE METHOD

IPC classification:
G10L 15/04, G10L 15/08, G10L 15/18, G10L 17/00, G10L 21/0208, G10L 21/028
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12734424

ENHANCEMENT OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

IPC classification:
A61K 35/14, A61K 35/28, A61P 35/00, C12N 5/0783
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13837673

STIMULATION OF OVARIAN FOLLICLE DEVELOPMENT AND OOCYTE MATURATION

IPC classification:
A61K 38/00, A61K 38/24
Applicant:
The Intellectual Property Management Center in the St. Mariana University School of Medicine
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13765696

IN VITRO PANCREATIC DIFFERENTIATION OF PLURIPOTENT MAMMALIAN CELLS

IPC classification:
C12N 5/071
Applicant:
Cambridge Enterprise Ltd.
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13839746

METHODS OF TREATING HEMATOLOGICAL MALIGNANCIES WITH NOTCH1 ANTIBODIES

IPC classification:
A61K 39/395, A61N 5/00, A61P 35/00, A61P 35/02
Applicant:
OncoMed Pharmaceuticals Inc
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11788706

PROTEIN ARRAYS AND METHODS OF USING AND MAKING THE SAME

IPC classification:
B01J 19/00, B82Y 30/00, C40B 50/14
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13848322

METHODS OF TREATING NEUROENDOCRINE TUMORS USING WNT PATHWAY-BINDING AGENTS

IPC classification:
A61K 39/395, C12N 15/11
Applicant:
OncoMed Pharmaceuticals Inc
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13851541

METHODS AND MONITORING OF TREATMENT WITH A DLL4 ANTAGONIST

IPC classification:
G01N 33/53
Applicant:
OncoMed Pharmaceuticals Inc
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14199035

Notch-binding agents and antagonists and methods of use thereof

IPC classification:
A61K 39/395, C07K 16/28
Applicant:
OncoMed Pharmaceuticals Inc
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP15159715

COMPOSITIONS AND METHODS FOR HIGH FIDELITY ASSEMBLY OF NUCLEIC ACIDS

IPC classification:
C12N 15/10, C12N 15/66, C12P 19/34, C40B 50/06, G06F 19/10
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP15170734

TARGETING OF BONE MARROW NEOVASCULATURE

IPC classification:
A61K 39/395, A61P 35/02, C07K 16/18
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14746505

METHODS AND MONITORING OF TREATMENT WITH A WNT PATHWAY INHIBITOR

IPC classification:
A61P 19/08
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14770132

METHODS FOR ANALYZING NUCLEIC ACIDS

IPC classification:
C12P 19/34, C12Q 1/68
Applicant:
Good Start Genetics Inc
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP13877452

AN INTEGRATED SYSTEM FOR LIBRARY CONSTRUCTION, AFFINITY BINDER SCREENING AND EXPRESSION THEREOF

IPC classification:
C12N 15/10, C12N 15/80
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14773248

COMPOSITIONS, METHODS AND APPARATUS FOR OLIGONUCLEOTIDES SYNTHESIS

IPC classification:
C12P 19/34, C40B 40/06, C40B 50/14
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14763776

DESETHYLHYDROXYCHLOROQUINE FOR THE TREATMENT OF DISEASES ASSOCIATED WITH INFLAMMATION

IPC classification:
A01N 43/54, A61K 31/505
Applicant:
Department of Veterans Affairs - Office of the General Counsel
Applicant:
Stanford University - Office of The General Counsel
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14780166

METHODS AND COMPOSITIONS FOR INHIBITING THE EFFECTS OF AMYLOID BETA OLIGOMERS

IPC classification:
C07K 1/00, C07K 14/00, C07K 17/00
Applicant:
Stanford University - Office of The General Counsel
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP14770177

SYSTEMS AND METHODS FOR TISSUE PROCESSING AND PREPARATION OF CELL SUSPENSION THEREFROM

IPC classification:
C12M 3/00
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14765235

MICROFLUIDIC METHODS FOR MANIPULATING DNA

IPC classification:
C12N 15/10, C12Q 1/68, G01N 27/26, G01N 27/447, G01N 33/00
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14769872

COMPOSITIONS AND METHODS FOR MULTIPLEX NUCLEIC ACIDS SYNTHESIS

IPC classification:
C07H 21/00, C07H 21/04, C12P 19/34
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14782093

CROSSLINKED CHITOSAN-LACTIDE HYDROGELS

IPC classification:
A61K 47/48
Applicant:
Stanford University - Office of The General Counsel
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15177553

METHODS AND DEVICES FOR NUCLEIC ACIDS SYNTHESIS

IPC classification:
C12N 15/10, C12N 15/66, C12P 19/34
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11743572

CORTICOGENESIS OF HUMAN PLURIPOTENT CELLS

IPC classification:
C12N 5/079, C12N 5/0797, C12Q 1/02
Applicant:
Cambridge Enterprise Ltd.
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15178099

COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING CANCER

IPC classification:
A61K 39/395, A61P 35/00, C07K 14/475, C07K 14/705, C07K 16/28, C12N 15/12
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14834669

METHODS OF TREATMENT OF HPV RELATED DISEASES

IPC classification:
A61K 39/12, A61P 31/20, A61P 35/00
Applicant:
Johns Hopkins University
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14749749

METHODS OF MODULATING SEED AND ORGAN SIZE IN PLANTS

IPC classification:
A61K 38/53, C07K 14/415, C12N 15/82
Applicant:
Plant Bioscience Limited
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14837955

METHODS AND SYSTEMS FOR ALIGNING SEQUENCES

IPC classification:
C12Q 1/68, G01N 33/50, G01N 33/574
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14842846

METHODS AND COMPOSITIONS FOR SELECTIVE AND TARGETED CANCER THERAPY

IPC classification:
A61K 31/426, A61K 31/428, A61P 35/00
Applicant:
The Board of Regents of the University of Texas System
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14850811

T CELL-INDUCING VACCINE CONTAINING INTEREPITOPE SEQUENCE PROMOTING ANTIGEN PRESENTATION

IPC classification:
A61K 39/00, A61K 47/36, A61K 48/00, A61P 31/04, A61P 31/12, A61P 35/00, C07K 14/00
Applicant:
Mie University
Applicant:
Kyoto University
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14847490

METHODS AND SYSTEM FOR DETECTING SEQUENCE VARIANTS

IPC classification:
C12Q 1/68, C40B 40/06, C40B 60/12, G06F 19/22
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14853307

METHODS FOR ASSESSING A GENOMIC REGION OF A SUBJECT

IPC classification:
C07H 21/02, C12P 19/34, C12Q 1/68, C40B 30/04
Applicant:
Good Start Genetics Inc
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14854801

METHODS AND SYSTEMS FOR GENOTYPING GENETIC SAMPLES

IPC classification:
G01N 1/00
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14803268

METHODS AND SYSTEMS FOR IDENTIFYING DISEASE-INDUCED MUTATIONS

IPC classification:
C12Q 1/68
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14789740

SYSTEMS AND METHODS FOR USING PAIRED-END DATA IN DIRECTED ACYCLIC STRUCTURE

IPC classification:
G06F 19/22
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14781860

IN VITRO PRODUCTION OF FOREGUT STEM CELLS

IPC classification:
C12N 5/071
Applicant:
Cambridge Enterprise Ltd.
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14857169

PAIN RELIEF FORMULATION AND METHOD OF TREATMENT

IPC classification:
A61K 31/045, A61K 31/165, A61K 36/38, A61K 36/61
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14802104

METHODS OF MODULATING SEED AND ORGAN SIZE IN PLANTS

IPC classification:
C07K 14/415, C12N 15/82
Applicant:
Plant Bioscience Limited
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP16155324

THERAPEUTIC COMBINATION AND USE OF DLL4 ANTAGONIST ANTIBODIES AND ANTI-HYPERTENSIVE AGENTS

IPC classification:
A61K 31/138, A61K 31/166, A61K 31/341, A61K 31/401, A61K 31/4184, A61K 31/4418, A61K 31/519, A61K 31/55, A61K 39/395, A61P 9/12, A61P 35/00
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP16157214

BIODEGRADATION PROCESS AND COMPOSITION

IPC classification:
C12N 1/00
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14867583

IDENTIFICATION OF PREDICTIVE BIOMARKERS ASSOCIATED WITH WNT PATHWAY INHIBITORS

IPC classification:
A61K 38/00, C12Q 1/68
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14827185

MODIFIED SERPINS FOR THE TREATMENT OF BLEEDING DISORDERS

IPC classification:
C07K 14/81
Applicant:
Cambridge Enterprise Ltd.
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14869059

TRANSGENIC NON-HUMAN MAMMAL EXPRESSING HUMAN MMP2

IPC classification:
A01K 67/027, C12N 15/09
Applicant:
Mie University
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14824390

PRODUCTION OF ENCODED CHEMICAL LIBRARIES

IPC classification:
C12N 15/10
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP15701278

SYSTEMS AND METHODS FOR USE OF KNOWN ALLELES IN READ MAPPING

IPC classification:
C12Q 1/68
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15737304

CYCLODEXTRIN COMPOSITIONS ENCAPSULATING A SELECTIVE ATP INHIBITOR AND USES THEREOF

IPC classification:
A61K 31/02, A61K 31/19, A61K 47/40, A61P 35/00
Applicant:
Johns Hopkins University
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15737117

LIPOSOME COMPOSITIONS ENCAPSULATING MODIFIED CYCLODEXTRIN COMPLEXES AND USES THEREOF

IPC classification:
A61K 9/127, A61K 31/7034, A61K 31/724, A61P 35/00
Applicant:
Johns Hopkins University
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15746255

GELATED IONIC LIQUID FILM-COATED SURFACES AND USES THEREOF

IPC classification:
H01M 6/22, H01M 8/18, H01M 10/0565
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15745937

ACTIVATION OF INNATE IMMUNITY FOR ENHANCED NUCLEAR REPROGRAMMING OF SOMATIC CELLS WITH mRNA

IPC classification:
A61K 45/00, C12N 5/00, C12N 15/00
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15748669

FLOWING ELECTROLYTE BATTERY SEPARATOR

IPC classification:
H01M 2/14, H01M 2/18, H01M 8/18
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP11700591

METHODS FOR PRODUCING ISOMERS OF MUCONIC ACID AND MUCONATE SALTS

IPC classification:
C12N 9/02, C12N 9/88, C12N 15/52, C12P 7/44
Applicant:
Amyris, Inc.
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP10784391

METHODS AND APPARATUSES FOR CHIP-BASED DNA ERROR REDUCTION

IPC classification:
C12Q 1/68
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11733320

WNT-BINDING AGENTS AND USES THEREOF

IPC classification:
C07K 16/18, C07K 16/22
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP10800922

BIODEGRADATION PROCESS AND COMPOSITION

IPC classification:
C11B 1/02, C12N 1/00
Agent:
Multiple attorneys, Arnold & Siedsma B.V.
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15714426

PURIFICATION OF DNA-CONJUGATE PRODUCTS

IPC classification:
C12N 15/10
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15768011

METHODS AND GENETIC SYSTEMS FOR CELL ENGINEERING

IPC classification:
A61K 48/00, C07H 21/04, C12N 5/00, C12N 15/00, C12N 15/74, C12N 15/87
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15773225

TREATMENT OF GASTRIC CANCER

IPC classification:
A61K 39/395, C07K 16/18, C07K 16/22
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP16179276

METHOD FOR TREATING MULTIPLE SCLEROSIS

IPC classification:
A61K 39/395, A61P 25/00
Applicant:
Genentech, Inc.
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
APPLICATION PUBLISHED
EP15719362

DOSING REGIMENS FOR TREATING AND/OR PREVENTING CEREBRAL AMYLOIDOSES

IPC classification:
A61K 31/445, A61P 25/28
Agent:
Miller Sturt Kenyon Ltd
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15720177

DIAGNOSTIC METHODS FOR NEURONAL DISORDERS

IPC classification:
G01N 33/487, G01N 33/50
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15725136

ANALYSIS OF COMPOUNDS FOR PAIN AND SENSORY DISORDERS

IPC classification:
G01N 33/50
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15720856

OPTOGENETIC ANALYSIS OF COMPOUNDS

IPC classification:
G01N 33/50
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15786354

EPITHELIAL ION CHANNEL (ENAC) BLOCKERS TO TREAT PSORIASIS

IPC classification:
A61K 31/4965
Applicant:
Stanford University - Office of The General Counsel
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15724350

METHODS OF CANCER THERAPY

IPC classification:
A61K 31/40, A61P 35/00, A61P 35/02
Applicant:
Cambridge Enterprise Ltd.
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15771240

METHOD FOR TESTING COMPOUNDS ON LIVING CELLS

IPC classification:
B01L 3/00, C12N 5/00
Applicant:
University of Limerick (University of Limerick)
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15770965

MICROFLUIDIC DEVICE WITH CHANNEL PLATES

IPC classification:
B01L 3/00
Applicant:
University of Limerick (University of Limerick)
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15729557

HUMAN LIVER SCAFFOLDS

IPC classification:
A61L 27/38, A61P 1/16
Applicant:
UCL Business plc
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15728120

COLLAGEN BIOMATERIALS

IPC classification:
A61L 27/24, A61L 27/52
Applicant:
UCL Business plc
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15818477

COMPOSITIONS AND METHODS FOR SITE-DIRECTED DNA NICKING AND CLEAVING

IPC classification:
C07H 21/00, C12N 9/16, C12N 15/00, C12P 19/34
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15822359

GALECTIN IMMUNOTHERAPY

IPC classification:
A61K 38/17, A61K 39/395, A61P 37/02
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15809732

COMPOSITIONS AND METHODS FOR THE EXPRESSION OF CRISPR GUIDE RNAS USING THE H1 PROMOTER

IPC classification:
C12N 9/16, C12N 15/63, C12N 15/79, C12N 15/85, C12N 15/861
Applicant:
Johns Hopkins University
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15745078

MAGNETIC ANASTOMOSIS DEVICES AND METHODS OF DELIVERY

IPC classification:
A61B 17/11
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15832300

RSPO1 BINDING AGENTS AND USES THEREOF

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15836791

COMBINATION THERAPY FOR TREATMENT OF CANCER

IPC classification:
A61K 31/337, A61K 38/17, A61K 39/395, A61P 35/00
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15838545

CORNEAL ENDOTHELIAL CELL MARKER

IPC classification:
A61L 27/00, C12N 5/10, C12N 15/09, C12Q 1/68
Applicant:
Osaka University
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP15838358

ACTIVATION OF MARROW INFILTRATING LYMPHOCYTES IN HYPOXIC ALTERNATING WITH NORMOXIC CONDITIONS

IPC classification:
A61K 35/17, A61K 35/28, A61P 35/00
Applicant:
Johns Hopkins University
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP15840263

STIMULATION OF OVARIAN FOLLICLE DEVELOPMENT AND OOCYTE MATURATION

IPC classification:
A61K 38/17, A61K 38/24, A61K 38/54
Applicant:
Stanford University - Office of The General Counsel
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP15841837

TREATMENT OF FIBROTIC DISEASES

IPC classification:
A61K 39/395
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP16204809

PVRIG BINDING AGENTS THAT MODULATE THE HIPPO PATHWAY AND USES THEREOF

IPC classification:
A61K 38/00, A61K 38/17, A61K 39/395, A61K 45/06, A61P 35/00, C07K 16/28, C12Q 1/02
Applicant:
OncoMed Pharmaceuticals Inc
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
The application has been published
EP15852140

METHODS FOR NUCLEIC ACID ASSEMBLY

IPC classification:
C12N 15/10
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP15797885

MODIFIED HETEROCYCLASE

IPC classification:
C12N 9/00
Applicant:
The University Court of the University of St. Andrews
Applicant:
University Court Of The University Of Aberdeen - Research and Innovation
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made
EP15865074

CELL AND TISSUE CULTURE CONTAINER

IPC classification:
A61L 27/38, B01L 3/00, C12M 3/00, C12Q 1/02
Agent:
Nicholas Robert Sutcliffe, Mewburn Ellis LLP
Status:
Request for examination was made

Please Sign in to use this feature